Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Pyrolytic hydrocarbon growth from cyclopentadiene.

The journal of physical chemistry. A·2010
Same author

In(III)-catalyzed tandem reaction of chromone-derived Morita-Baylis-Hillman alcohols with amines.

Organic & biomolecular chemistry·2010
Same author

Regression-based multi-trait QTL mapping using a structural equation model.

Statistical applications in genetics and molecular biology·2010
Same author

Elevated expression of APE1/Ref-1 and its regulation on IL-6 and IL-8 in bone marrow stromal cells of multiple myeloma.

Clinical lymphoma, myeloma & leukemia·2010
Same author

Accelerated aging of intervertebral discs in a mouse model of progeria.

Journal of orthopaedic research : official publication of the Orthopaedic Research Society·2010
Same author

The synthesis of a multiblock osteotropic polyrotaxane by copper(I)-catalyzed huisgen 1,3-dipolar cycloaddition.

Macromolecular bioscience·2010

Related Experiment Video

Updated: Aug 10, 2025

Microfluidic Production of Lysolipid-Containing Temperature-Sensitive Liposomes
09:51

Microfluidic Production of Lysolipid-Containing Temperature-Sensitive Liposomes

Published on: March 3, 2020

9.1K

Pyrophosphorylated-Cholesterol-Modified Bone-Targeting Liposome Formulation Procedure.

Yanzhi Liu1,2, Zhenshan Jia1, Luoyang Ma2

  • 1Department of Pharmaceutical Sciences, College of Pharmacy, University of Nebraska Medical Center, Omaha, NE, USA.

Methods in Molecular Biology (Clifton, N.J.)
|February 13, 2023
PubMed
Summary

This study introduces a novel, biodegradable pyrophosphorylated cholesterol liposome for targeted bone drug delivery. This system enhances treatment efficacy for bone fractures and diseases with minimal safety concerns.

Keywords:
BoneBone targetingDrug deliveryLiposomesPyrophosphatePyrophosphorylated cholesterol

More Related Videos

Preparation, Administration, and Assessment of In Vivo Tissue-Specific Cellular Uptake of Fluorescent Dye-Labeled Liposomes
08:44

Preparation, Administration, and Assessment of In Vivo Tissue-Specific Cellular Uptake of Fluorescent Dye-Labeled Liposomes

Published on: July 30, 2020

4.6K
One Minute, Sub-One-Watt Photothermal Tumor Ablation Using Porphysomes, Intrinsic Multifunctional Nanovesicles
09:51

One Minute, Sub-One-Watt Photothermal Tumor Ablation Using Porphysomes, Intrinsic Multifunctional Nanovesicles

Published on: September 17, 2013

10.9K

Related Experiment Videos

Last Updated: Aug 10, 2025

Microfluidic Production of Lysolipid-Containing Temperature-Sensitive Liposomes
09:51

Microfluidic Production of Lysolipid-Containing Temperature-Sensitive Liposomes

Published on: March 3, 2020

9.1K
Preparation, Administration, and Assessment of In Vivo Tissue-Specific Cellular Uptake of Fluorescent Dye-Labeled Liposomes
08:44

Preparation, Administration, and Assessment of In Vivo Tissue-Specific Cellular Uptake of Fluorescent Dye-Labeled Liposomes

Published on: July 30, 2020

4.6K
One Minute, Sub-One-Watt Photothermal Tumor Ablation Using Porphysomes, Intrinsic Multifunctional Nanovesicles
09:51

One Minute, Sub-One-Watt Photothermal Tumor Ablation Using Porphysomes, Intrinsic Multifunctional Nanovesicles

Published on: September 17, 2013

10.9K

Area of Science:

  • Biomaterials Science
  • Drug Delivery Systems
  • Nanotechnology

Background:

  • Bone-targeting drug delivery systems are crucial for treating musculoskeletal diseases, often relying on hydroxyapatite-affine ligands.
  • Traditional ligands like bisphosphonates have limitations; pyrophosphorylated cholesterol offers a biodegradable alternative with strong bone affinity.

Purpose of the Study:

  • To describe the synthesis of pyrophosphorylated cholesterol.
  • To detail a liposome formulation protocol for hydrophilic drug encapsulation using this modified ligand.
  • To provide methods for evaluating the bone-targeting properties of the liposomes in vitro and in vivo.

Main Methods:

  • Synthesis of pyrophosphorylated cholesterol ligand.
  • Reverse-evaporation method for formulating pyrophosphorylated-cholesterol-modified liposomes.
  • In vitro and in vivo evaluation of liposome bone-targeting efficacy.

Main Results:

  • Successful synthesis of pyrophosphorylated cholesterol.
  • Development of a liposome formulation capable of encapsulating hydrophilic drugs.
  • Demonstrated bone-targeting capabilities of the modified liposomes in biological models.

Conclusions:

  • Pyrophosphorylated cholesterol-modified liposomes represent a safe and effective bone-targeting drug delivery system.
  • This system shows promise for treating conditions like fracture delayed union and nonunion.
  • The technology may be applicable to other bone anabolic agents for various bone diseases.